All In MedTech

FDA Clearance Tracker · K242467

IQ-UIP

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Dec 19, 2024 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Dec 19, 2024

Substantially Equivalent

Time to decision

121 days

Received Aug 20, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K242467
Device name
IQ-UIP
Applicant
Imbio, Inc.
Applicant location
Minneapolis, MN
Received
Aug 20, 2024
Decided
Dec 19, 2024
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 892.2085

Every decision under product code QWO

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code QWO. The earliest in FDA's data is DEN220040, decided Jan 12, 2024.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Imbio, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.